Filter
4159
Filtered Results: 4159
Text search:
Point-of-Care-Testing
Featured
Recommendations
439
New Publications
1136
Language
Document type
No document type
2414
Guidelines
593
Studies & Reports
569
Manuals
236
Strategic & Response Plan
163
Training Material
78
Fact sheets
52
Situation Updates
33
Infographics
10
Resource Platforms
5
Brochures
3
Online Courses
2
App
1
Countries / Regions
India
198
Kenya
145
Global
139
South Africa
110
Nigeria
99
Liberia
93
Sierra Leone
91
Tanzania
89
Ethiopia
86
Malawi
82
Uganda
80
Nepal
73
Zambia
73
Africa
72
Western and Central Europe
71
Rwanda
62
Ghana
61
Myanmar / Burma
54
Bangladesh
53
Namibia
43
Ukraine
38
Zimbabwe
36
Philippines
36
Lesotho
36
Latin America and the Carribbean
35
Congo, Democratic Republic of
34
Syria
31
South–East Asia Region
26
Eastern Europe
26
East and Southern Africa
25
West and Central Africa
24
Senegal
23
Cambodia
23
Mozambique
21
Guinea
20
South Sudan
20
Botswana
20
Asia
20
Indonesia
17
Haiti
16
Germany
16
Yemen
16
Russia
16
Burkina Faso
14
Eastern Europe and Central Asia
14
Pakistan
13
Eswatini/ Swaziland
13
Afghanistan
12
Brazil
12
Middle East and North Africa
12
Western Pacific Region
11
Moldova
10
Somalia
9
Central African Republic
9
Colombia
9
Mali
8
Cameroon
8
Lebanon
8
Sudan
8
USA
7
Iraq
7
Jordan
7
Thailand
7
Peru
7
Venezuela
7
Southern Africa
7
China
6
Albania
6
Tajikistan
6
Vietnam
6
Papua New Guinea
5
Benin
5
North Macedonia
5
Madagascar
5
Sri Lanka
5
Burundi
4
Poland
4
Palestine
4
Côte d’Ivoire / Ivory Coast
3
Saudi Arabia
3
Egypt
3
Argentina
3
Serbia
3
Bolivia
3
Libya
3
Angola
3
Bhutan
3
Timor Leste/ East Timor
3
Romania
3
Georgia
3
Mauritius
3
Guinea-Bissau
2
Togo
2
Turkey
2
Gambia
2
Hungary
2
Ecuador
2
Mexico
2
Chile
2
Djibouti
2
Armenia
2
Laos
2
Bulgaria
2
Iran
2
United Kingdom
2
Chad
1
Honduras
1
El Salvador
1
Guatemala
1
Italy
1
Qatar
1
Estonia
1
Slovakia
1
North America
1
Gabon
1
Turkmenistan
1
Jamaica
1
Denmark
1
Maldives
1
Spain
1
Belarus
1
Bosnia and Herzegovina
1
Authors & Publishers
Publication Years
Category
Countries
1603
Clinical Guidelines
366
Public Health
190
Women & Child Health
190
Key Resources
165
Capacity Building
112
Pharmacy & Technologies
72
Toolboxes
HIV
521
COVID-19
414
TB
302
Mental Health
177
AMR
176
Rapid Response
137
Ebola
123
Disability
109
Caregiver
107
NTDs
100
Pharmacy
72
Conflict
68
Planetary Health
68
Refugee
55
NCDs
55
Global Health Education
33
Natural Hazards
28
Health Financing Toolbox
27
Cholera
25
Specific Hazards
24
Polio
20
Zika
20
Social Ethics
7
South Sudan
1
Nature Reviews Microbiology Vol. 17 (2019)pp.51-62
Antimicrobial susceptibility testing (AST) technologies help to accelerate the
initiation of targeted antimicrobial therapy for patients with inf...
The method, entitled “elicit-provide-elicit”, is a patient centred method which is adaptable to a range of clinical situations. Recent clinical trials show that the introduction of advanced com...
The National Department of Health and Department of Agriculture, Forestry and Fisheries have collectively engaged to determine the key interventions that will form the basis for this strategy taking...
Polymerase Chain Reaction (PCR) has significantly helped in early diagnosis and commencement of specific interventions for diseases control. It also plays a critical role in understanding the disease epidemiology and unraveling the transmissio...
While epidemiological data for type 1 diabetes (T1D) in low/middle-income countries, and particularly low-income countries (LICs) including Liberia is lacking, prevalence in LICs is thought to be increasing. T1D care in LICs is often impacted by cha...
First published in 2020, this toolkit is intended for clinicians working in acute care, managing adult and paediatric patients with acute respiratory infection, including severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock...
This publication is an updated version of the Management of Tuberculosis and HIV Coinfection clinical protocol released in 2007 by the WHO Regional Office for Europe. It is intended for all health <... workers involved in preventing, diagnosing, treating and caring for people living with TB and HIV in the specific settings of the WHO European Region.
Many low-resource settings have a shortage of physicians and health workers. (1) In order to provide patient-centred continuous care more effectively, primary ... systems can include team-based care strategies in their clinic workflows and protocols. Team-based care uses multidisciplinary teams (which may involve new staff, or the shifting of tasks among existing staff). Teams can include patients themselves, primary care physicians, and other allied health professionals, such as nurses, pharmacists, counsellors, social workers, nutritionists, community health workers, or others. Teams reduce the burden on physicians by utilizing the skills of trained health workers. Strong evidence shows that team-based care is effective in improving hypertension control among patients in a cost-effective way. (2) Some amount of task shifting/team-based care is already taking place in many settings; this module provides further guidance on how to maximize this approach for greater impact.
The speed of developing diagnostics for SARS-CoV-2, the causative agent of coronavirus disease 2019 (COVID-19), has been quite remarkable. Diagnostics have focused on nucleic acid amplification ... (NAAT) to identify infected individuals in acute-phase disease for timely implementation of mitigation strategies and case management. More and more immunodiagnostics, mostly rapid diagnostic tests, are being made available as an alternative to NAATs. This type of test can be used out-of-laboratory conditions at large scale.
16 Dec. 2020
This document provides guidance to Ministries of Health (MOHs), laboratory personnel and implementing partners in African Union Member States on the application of rapid antigen tests ...
Policy brief, 24 July 2020
The COVID-19 pandemic has affected older people disproportionately, especially those living in long-term care facilities. In many countries, evidence shows that more than 40% of... COVID-19 related deaths have been linked to long-term care facilities, with figures being as high as 80% in some high-income countries. Concerted action is needed to mitigate the impact across all aspects of long-term care, including home- and community-based care, given that most users and providers of care are those who are vulnerable to severe COVID-19.
This policy brief provides 11 policy objectives and key action points to prevent and manage COVID-19 across long-term care. Its intended audience is policy makers and authorities (national, subnational and local) involved in the COVID-19 pandemic. The brief builds on currently available evidence on the measures taken to prevent, prepare for and respond to the COVID‑19 pandemic across long-term care services including care providers
This report offers a summary of the provided support and recommendations on priority activities for IPC improvement at national and facility levels. The COVID-19 pandemic spotlighted areas for improvement in the IPC programme at national and facilit...
This publication is based on the list of clinical interventions selected from clinical guidelines on prevention, screening, diagnosis, treatment, palliative care, monitoring and end ... life care. This publication addresses medical devices for six types of cancer: breast, cervical, colorectal, leukemia, lung and prostate. The first section defines the global increase in cancer cases, the global goals to manage NCDs and the WHO activities related to these goals. The second section presents the methodology used for the selection of medical devices that support clinical interventions required to screen, diagnose, treat and monitor cancer stages, as well as the provision of palliative care, based on evidence-based information. The third section lists the priority medical devices required to manage cancer in seven different units of health care services: 1. Vaccination, clinical assessment and endoscopy, 2. Medical imaging and nuclear medicine, 3. Surgery, 4. Laboratory and pathology, 5. Radiotherapy, 6. Systemic therapy and 7. Palliative and end of life care
Despite recent global declines, under-five mortality remains high in many of the poorest countries. Barriers to timely
quality care, including user fees, distance to facilities and the availabilit...
Non-Wood Forest Products 11
Traditional medicine and its use of medicinal plants is dependent on reliable supply of plant materials. The book focuses on the interface between medicinal plant use an...
Myanmar is one of the world’s 22 high tuberculosis (TB) burden countries, and supporting TB control in Myanmar is a global priority. This report reflects the findings, discussions, conclusions and recommendations ... the fourth international review mission of the Myanmar National TB Programme (NTP), which brought together international and national partners to review progress in TB control and to offer guidance on future TB control directions and efforts.
A high-quality national disease prevalence survey completed in 2010 demonstrated a TB disease burden two to three times higher than anticipated on the basis of previous surveys. In 2011 about 200 000 adults and children will have developed TB, including 20 000 HIV infected and 9000 suffering from MDR-TB, both of which will require additional care and costly treatment. TB remains among the top killers of adults, and more women die of TB than from maternal causes.
A high-quality national disease prevalence survey completed in 2010 demonstrated a TB disease burden two to three times higher than anticipated on the basis of previous surveys. In 2011 about 200 000 adults and children will have developed TB, including 20 000 HIV infected and 9000 suffering from MDR-TB, both of which will require additional care and costly treatment. TB remains among the top killers of adults, and more women die of TB than from maternal causes.
USAID funded/ Primary Health Care Project in Iraq (PHCPI) in cooperation with Iraqi Ministry of Health (MOH) aims to promote Primary Health Care (P...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability ... DAAs has improved significantly, but access remains lim-
ited. Initially, due to their high prices, affordability of DAAs was limited in high-, middle- and low-
income countries alike. Now there is a divide between those countries where, because of intellectual
property barriers, prices have remained (very) high and other countries where generics are, or can be,
available at much lower prices. The result is a dual market
These are integrated National Guidelines 2013 for Prevention and Management of HIV, STIs & Other Blood Borne Infections in accordance with the last guidelines of the World Health Organization (WHO) ...
This analytical report reviews and discusses the potential role and influence of political commitment in implementing endorsements and conducting policy in the field of tuberculosis (TB) prevention ...
